In contrast, the concentration of MMP-9 in the plasma of BM aspirates was highest in patients with CML versus healthy controls and patients with B-ALL (Fig. S11B). This evidence concerns the gene MMP9 and chronic myelogenous leukemia, BCR-ABL1 positive.